MAFA
BSX icon

MJT & Associates Financial Advisory’s Boston Scientific BSX Stock Holding History

MJT & Associates Financial Advisory’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-63
Closed -$2.69K – 446
2026
Q2 		$2.69K Hold
63
– – ﹤0.01% 360
2026
Q1 		$3.95K Hold
63
– – ﹤0.01% 300
2025
Q4 		$6.01K Hold
63
– – ﹤0.01% 256
2025
Q3 		$6.15K Hold
63
– – 0.01% 262
2025
Q2 		$6.77K Hold
63
– – 0.01% 268
2025
Q1 		$6.36K Buy
+63
New +$6.34K 0.01% 273

Other funds holding BSX

GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
PA
Persium Advisors Atlanta, Georgia $191M AUM 23.01% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

MJT & Associates Financial Advisory's BSX Position: Q3 2026 in Review

MJT & Associates Financial Advisory sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 63 shares — an estimated $2.69K sold.

MJT & Associates Financial Advisory first reported a position in BSX in Q1 2025 and held it in 6 quarters. The position peaked at $6.77K in Q2 2025. 43 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • MJT & Associates Financial Advisory reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • MJT & Associates Financial Advisory sold 63 Boston Scientific shares in Q3 2026, an estimated $2.69K.
  • MJT & Associates Financial Advisory first reported a position in Boston Scientific in Q1 2025 and held it in 6 quarters.
  • MJT & Associates Financial Advisory's Boston Scientific position peaked at $6.77K in Q2 2025.
  • 43 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.